Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio, a China biopharma based in...
3SBio, a Shenyang biotech, rose 5% in...
3SBio of Shenyang rose 5% in its first...
China's 3SBio obtained global rights to...
3SBio of Shenyang acquired Zhejiang...
3SBio of Shenyang acquired Zhejiang...
3SBio of Shenyang expanded its...
3SBio of Shenyang and Sorrento...
3SBio of Shenyang will pay $290 million...
3SBio reported the CFDA formally...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China